Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
11.80
-0.15 (-1.26%)
At close: Jun 6, 2025, 4:00 PM
11.81
+0.01 (0.08%)
After-hours: Jun 6, 2025, 4:04 PM EDT

Aardvark Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
26.561.649.7415.56
Short-Term Investments
124.7612.020.250.55
Cash & Short-Term Investments
151.2673.669.9916.11
Cash Growth
1414.27%637.44%-37.98%-
Prepaid Expenses
3.290.310.250.32
Other Current Assets
-0.160.130.07
Total Current Assets
154.5574.1410.3716.49
Property, Plant & Equipment
0.630.740.160.25
Other Long-Term Assets
1.842.640.010.01
Total Assets
157.0377.5110.5416.76
Accounts Payable
2.562.31.040.26
Accrued Expenses
3.032.290.240.24
Current Portion of Leases
0.390.340.110.1
Total Current Liabilities
5.984.931.380.6
Long-Term Leases
0.340.440.050.16
Other Long-Term Liabilities
0.020.0300.02
Total Liabilities
6.345.391.430.78
Additional Paid-In Capital
218.283.682.942.61
Retained Earnings
-67.64-58.33-37.74-30.53
Total Common Equity
150.69-54.64-34.8-27.92
Shareholders' Equity
150.6972.119.115.98
Total Liabilities & Equity
157.0377.5110.5416.76
Total Debt
0.730.780.160.26
Net Cash (Debt)
150.5372.889.8315.84
Net Cash Growth
1431.84%641.67%-37.97%-
Net Cash Per Share
23.8818.242.484.07
Filing Date Shares Outstanding
21.721.73.973.89
Total Common Shares Outstanding
21.74.073.973.89
Working Capital
148.5869.218.9915.9
Book Value Per Share
6.95-13.44-8.77-7.18
Tangible Book Value
150.69-54.64-34.8-27.92
Tangible Book Value Per Share
6.95-13.44-8.77-7.18
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q